Analysis shows aspirin’s potential adverse effect on mood in older adults with pre-existing depression ...
Researchers
Meet the team: Introducing a US ASPREE investigator
Above: Prof Mike Ernst is a US based investigator to the ASPREE project. Meet Professor Mike Ernst Michael E....
Aspirin and major gastrointestinal bleeding risk
New analysis identifies potential risk of major GI bleeding in older adults A closer analysis of data from the...
Observational statin study in ASPREE participants
Statins may prevent heart attacks and strokes but may not prolong life free of disability PRESS RELEASE...
Low-dose aspirin and depression
ASPREE-D sub-study finds daily aspirin not protective against late-life depression PRESS RELEASE: 4th June 2020...
Aspirin and cognitive decline
Daily low-dose aspirin does not prevent cognitive decline in healthy older adults PRESS RELEASE: 1st...
ASPREE’s Australian award trifecta
Impact of ASPREE trial on public health recognised We are pleased to share three Australian research...
NIH funds ASPREE-XT (eXTension) study
Landmark study to assess long-term health risks and benefits of prior aspirin use in elderly PRESS RELEASE ...
Researchers from National Cancer Institute (NCI) visit ASPREE
A welcome to Melbourne Australian ASPREE investigators welcomed members from the National Cancer Institute...
US heart specialists pen importance of ASPREE trial to clinicians
The ASPREE Aftermath: A Geriatric Perspective on the Role of Aspirin in Older Adults Thanks to...